UniQure says FDA prefers randomized trial for Huntington’s treatmentnews2026-03-02T12:35:27+00:00March 2nd, 2026|Endpoints News|
Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapynews2026-02-25T12:00:38+00:00February 25th, 2026|Endpoints News|
BioMarin fails to find buyer, pulls Roctavian gene therapy off marketnews2026-02-24T16:17:44+00:00February 24th, 2026|Endpoints News|
FDA unveils long-awaited guidance on new pathway for individualized therapiesnews2026-02-23T16:30:45+00:00February 23rd, 2026|Endpoints News|
First test of gene therapy for rare form of autism is underwaynews2026-02-23T14:00:16+00:00February 23rd, 2026|Endpoints News|
NeuExcell Therapeutics’ brain cancer therapy tests debated fieldnews2026-02-18T12:00:07+00:00February 18th, 2026|Endpoints News|
Boehringer Ingelheim stops work on inhaled cystic fibrosis gene therapynews2026-02-17T11:03:37+00:00February 17th, 2026|Endpoints News|
Lilly joins in vivo CAR-T sprint with $2.4B Orna acquisitionnews2026-02-09T15:25:12+00:00February 9th, 2026|Endpoints News|
China startup AccurEdit raises $75M for gene editing therapiesnews2026-02-03T16:13:27+00:00February 3rd, 2026|Endpoints News|
Ultragenyx unwraps data that may be central to its gene therapy resubmissionnews2026-02-03T13:00:48+00:00February 3rd, 2026|Endpoints News|
